N-[4-(1-oxopropyl)phenyl]acetamide
- CAS NO.:16960-49-9
- Empirical Formula: C11H13NO2
- Molecular Weight: 191.23
- MDL number: MFCD00017281
- EINECS: 241-032-7
- SAFETY DATA SHEET (SDS)
- Update Date: 2022-12-21 16:56:50
Properties of N-[4-(1-oxopropyl)phenyl]acetamide
Melting point: | 172-173℃ |
Boiling point: | 398℃ |
Density | 1.121 |
Flash point: | 173℃ |
storage temp. | 2-8°C |
pka | 14.54±0.70(Predicted) |
EPA Substance Registry System | Acetamide, N-[4-(1-oxopropyl)phenyl]- (16960-49-9) |
Safety information for N-[4-(1-oxopropyl)phenyl]acetamide
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for N-[4-(1-oxopropyl)phenyl]acetamide
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
Levosimendan Impurity 8
(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-
N-[4-(2-bromopropanoyl)phenyl]acetamide
4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile
Levosimendan-001
Levosimendan
Acetic acid, 2-cyano-2-[2-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]-, ethyl ester
You may like
-
16960-49-9 4-ACETAMIDOPROPIOPHENONE 98%View Details
16960-49-9 -
16960-49-9 98%View Details
16960-49-9 -
4''-PROPIONYLACETANILIDE CAS 16960-49-9View Details
16960-49-9 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
Lithium ClavulanateView Details
61177-44-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.